TY  - JOUR
T1  - Effects of Pleurotus Eryngii (DC.) Quél. Mushroom Extracts on Cell Proliferation in Breast and Colon Cancer Cell Lines
AU  - Cömert Önder, Ferah
AU  - Davutlar, Gülce
AU  - Önder, Alper
AU  - Allı, Hakan
AU  - Ay, Mehmet
PY  - 2024
DA  - September
Y2  - 2024
DO  - 10.28979/jarnas.1499726
JF  - Journal of Advanced Research in Natural and Applied Sciences
JO  - JARNAS
PB  - Çanakkale Onsekiz Mart University
WT  - DergiPark
SN  - 2757-5195
SP  - 659
EP  - 668
VL  - 10
IS  - 3
LA  - en
AB  - This study was aimed to collect Pleurotus eryngii (DC.) Quél. edible/medicinal mushroom from Çanakkale/Kumkale and to evaluate the antiproliferative effects of alcoholic extracts on breast and colon cancer cell lines. For this purpose, the Soxhlet method prepared methanol and ethanol:H2O (70:30) extracts by gradually increasing solvent polarities. Then, breast (MDA-MB-231, BT-549, BT-20, MCF-7) and colon (HT-29) cancer cell lines were treated with the extracts in increasing concentrations (0.05-0.5 mg/mL) for 48 h. In conclusion, methanol and aqueous ethanol extracts exhibited significant antiproliferative effects in cancer cell lines, according to the MTT assay. The cell viability in the triple-negative breast cancer (TNBC) MDA-MB-231 cell line was highly decreased by methanol extract at a very low concentration (0.1 mg/mL). Furthermore, methanol extract at 0.3 mg/mL reduced the percentage of cell viability in the HT-29 cell line. Aqueous ethanol extract showed antiproliferative activity in breast and colon cancer cell lines at 0.25 mg/mL concentration for 48 h applications. In addition, some bioactive components such as 4-hydroxy flavone, chrysin, and tannic acid of aqueous ethanol extract have been determined by High-Performance Liquid Chromatography (HPLC) analysis. As a result, this study may increase interest in the studies on the anti-cancer activities and the mechanisms of P. eryngii mushroom.
KW  - Pleurotus eryngii (DC.) Quél.
KW  - mushroom
KW  - antiproliferation
KW  - natural products
KW  - cancer
CR  - K. Kumar, R. Mehra, R. P. F. Guiné, M. J. Lima, N. Kumar, R. Kaushik, N. Ahmed, A. N. Yadav, H. Kumar, Edible mushrooms: A comprehensive review on bioactive compounds with health benefits and processing aspects, National Library of Medicine 10 (12) (2021) 2996.
CR  - G. Anusiya, U. Gowthama Prabu, N.V. Yamini, N. Sivarajasekar, K. Rambabu, G. Bharath, F. Banat, A review of the therapeutic and biological effects of edible and wild mushrooms, Bioengineered 12 (2) (2021) 11239-11268.
CR  - R. Garcia-Rubio, H. C. de Oliveira, J. Rivera, N Trevijano-Contador, The fungal cell wall: Candida, cryptococcus and aspergillus species, Frontiers in Microbiology 10 (2020) 2993.
CR  - A. Assemie, G. Abaya, The effect of edible mushroom on health and their biochemistry, International Journal of Microbiology 2022 (2022) 8744788.
CR  - P. A. Ayeka, Potential of mushroom compounds as immunomodulators in cancer immunotherapy: A review, Evidence Based Complementary and Alternative Medicine (2018) 7271509.
CR  - R. L. Siegel, K. D. Miller, N. S. Wagle, A. Jemal, Cancer statistics, CA Cancer Journal for Clinicians 73 (1) (2023) 17-48.
CR  - M. Borówka, S. Łącki-Zynzeling, M. Nicze, S. Kozak, J. Chudek, adverse renal effects of anti-cancer immunotherapy: A review, Cancers Basel 14 (17) (2022) 4086.
CR  - H. S. Chen, Y. F. Tsai, S. Lin, C. C. Lin, K. H. Khoo, C. H. Lin, C. H. Wong, Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides, Bioorganic Medicinal 
Chemistry 12 (21) (2004) 5595-5601.
CR  - M. B. Gariboldi, E. Marras, N. Ferrario, V. Vivona, P. Prini, F. Vignati, G Perletti, Anti-cancer potential of edible/medicinal mushrooms in breast cancer, International Journal of Molecular Sciences 24 (12) (2023) 10120.
CR  - S. K. Panda, G. Sahoo, S. S. Swain, W. Luyten, Anti-cancer activities of mushrooms: A neglected source for drug discovery, Pharmaceuticals Basel 15 (2) (2022) 176.
CR  - S. P. Wasser, Medicinal mushrooms as a source of anti-tumor and immunomodulating polysaccharides, Applied Microbiology and Biotechnology 60 (3) (2002) 258–274.
CR  - A. M. Mariga, F. Pei, W. J. Yang, L. Y. Zhao, Y. N. Shao, D. K. Mugambi, Q. H. Hu, Immunopotentiation of Pleurotus eryngii (DC. ex Fr.) quel, Journal of Ethnopharmacology 153 (3) (2014) 604-14.
CR  - X. Shi, Y. Zhao, Y. Jiao, T. Shi, X. Yang, ROS-dependent mitochondria molecular mechanisms underlying anti-tumor activity of Pleurotus abalonus acidic polysaccharides in human breast cancer MCF-7 cells, PLoS One 8 (5) (2013).
CR  - M. C. Radhakrishnan, N. Peter, Biological Properties of silver nanoparticles from β (1–3) glucan isolated from the edible mushroom Pleurotus florida, Letters Applied NanoBioScience 10 (2020) 2096–2106.
CR  - J-T. Lin, C-W. Liu, Y-C. Chen, C-C. Hu, L-D. Juang, C-C. Shiesh, D-J. Yang, Chemical composition, antioxidant and anti-inflammatory properties for ethanolic extracts from Pleurotus eryngii fruiting bodies harvested at different time, LWT - Food Science and Technology 55 (2014) 374–382.
CR  - C. Sánchez, Cultivation of Pleurotus ostreatus and other edible mushrooms, Applied Microbiology and Biotechnology 85 (2010) 1321–1337.
CR  - R. C. G. Corrêa, T. Brugnari, A. Bracht, R. M. Peralta, I. C. F. R. Ferreira, Biotechnological, nutritional and therapeutic uses of Pleurotus spp. (Oyster mushroom) related with its chemical composition: A review on the past decade findings, Trends in Food Science and Technology 50 (2016) 103–117.
CR  - D. Sande, G. P. de Oliveira, M. A. F. Moura, B. de Almeida Martins, M. T. N. S. Lima, J. A. Takahashi, Edible mushrooms as a ubiquitous source of essential fatty acids, Food Research International 125 (2018) 108524.
CR  - H. Allı, S. Özderin, İ. Kıvrak, Ege bölgesinde yetişen körek mantarı (Pleurotus eryngii (DC.) quél.)’nın yağ asidi içeriğinin belirlenmesi, Mantar Dergisi 13 (3) (2022) 26-31.
CR  - S. W. Kim, H. G. Kim, B. E. Lee, H. H. Hwang, D. H. Baek, S. Y. Ko, Effects of mushroom, Pleurotus eryngii, extracts on bone metabolism, Clinical Nutrition 25 (1) (2006) 166–170.
CR  - M. Stajić, J. Vukojeviċ, V. Sonja, Biology of Pleurotus eryngii and role in biotechnological processes: A review, Critical Reviews in Biotechnology 29 (1) (2009) 55–66.
CR  - Y. Kocak, I. Meydan, T. Gur Karahan, F. Sen, Investigation of mycosynthesized silver nanoparticles by the mushroom Pleurotus eryngii in biomedical applications, International Journal of Environmental Science and Technology 20 (2023) 4861–4872.
CR  - F. Cömert Önder, S. Kalın, Ö. Maraba, A. Önder, P. Ilgın, E. Karabacak, Anti-cancer, antioxidant, antimicrobial activities, and HPLC analysis of alcoholic extracts of Parthenocissus quinquefolia l. plant collected from Çanakkale, Journal of Advanced Research in Natural and Applied Sciences 10 (1) (2024) 116-133.
CR  - K. Sorimachi, K. Akimoto, Y. Ikehara, K. Inafuku, A. Okubo, S. Yamazaki, Secretion of TNF-α, IL-8 and nitric oxide by macrophages activated with Agaricus blazei Murill fractions in vitro, Cell Structure and Function 26 (2) (2001) 103–108.
CR  - B. S. Min, J. J. Gao, N. Nakamura, M. Hattori, Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against Meth-A and LLC tumor cells, Pharmaceutical Bulletin 48 (7) (2000) 1026–1033.
CR  - S. C. Hsu, C. C. Ou, J. W. Li, T.C. Chuang, H. P. Kuo, J. Y. Liu, C. S. Chen, S. C. Lin, C. H. Su, M. C. Kao, Ganoderma tsugae extracts inhibit colorectal cancer cell growth via G2/M cell cycle arrest, Journal of Ethnopharmacology 120 (3) (2008) 394–401.
CR  - L. Li, Y. Wang, Progress on experimental research and clinical application of trametes robiniophila, China Cancer 16 (2006) 110–113.
CR  - U. Munawer, V. B. Raghavendra, S. Ningaraju, K. L. Krishna, A. R. Ghosh, G. Melappa, A. Pugazhendhi, Biofabrication of gold nanoparticles mediated by the endophytic Cladosporium species: Photodegradation, in vitro anti-cancer activity and in vivo anti-tumor studies, International Journal of Pharmaceutics 588 (2020).
CR  - M. van Barele, B. A. M. Heemskerk-Gerritsen, Y. V. Louwers, M. B. Vastbinder, J. W. M. Martens, M. J. Hooning, A. Jager, Estrogens and progestogens in triple negative breast cancer: do they harm?, Cancers Basel 13 (11) (2021) 2506.
CR  - Q. Wu, S. Siddharth, D. Sharma, Triple negative breast cancer: A mountain yet to be scaled despite the triumphs, Cancers Basel 13 (15) (2021) 3697.
CR  - F. T. Kolligs, Diagnostics and epidemiology of colorectal cancer, Visceral Medicine 32 (3) (2016) 158-64.
CR  - M. P. Pathak, K. Pathak, R. Saikia, U. Gogoi, M. Z. Ahmad, P. Patowary, A. Das, Immunomodulatory effect of mushrooms and their bioactive compounds in cancer: A comprehensive review, Biomedicine and Pharmacotherapy 149 (2022) 112901.
CR  - F. S. Reis, A. Martins, L. Barros, I. C. Ferreira, Antioxidant properties and phenolic profile of the most widely appreciated cultivated mushrooms: A comparative study between in vivo and in vitro samples, Food and Chemical Toxicology 50 (5) (2012) 1201-1227.
CR  - D. Ren, N. Wang, J. Guo, L. Yuan, X. Yang, Chemical characterization of Pleurotus eryngii polysaccharide and its tumor-inhibitory effects against human hepatoblastoma HepG-2 cells, Carbohydrate Polymers 138 (2016) 123-133.
UR  - https://doi.org/10.28979/jarnas.1499726
L1  - https://dergipark.org.tr/en/download/article-file/3999258
ER  -